![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2022
Orben, Felix; Lankes, Katharina; Schneeweis, Christian; Hassan, Zonera; Jakubowsky, Hannah; Krauss, Lukas; Boniolo, Fabio; Schneider, Carolin; Schaefer, Arlett; Murr, Janine; Schlag, Christoph; Kong, Bo; Oellinger, Rupert; Wang, Chengdong; Beyer, Georg; Mahajan, Ujjwal M.; Xue, Yonggan; Mayerle, Julia; Schmid, Roland M.; Kuster, Bernhard; Rad, Roland; Braun, Christian J.; Wirth, Matthias; Reichert, Maximilian; Saur, Dieter und Schneider, Guenter
(2022):
Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype.
In: Jci Insight, Bd. 7, Nr. 10, 151353
2021
Mahajan, Ujjwal M.; Li, Qi; Alnatsha, Ahmed; Maas, Jessica; Orth, Michael; Maier, Sebastian Hubertus; Peterhansl, Julian; Regel, Ivonne; Sendler, Matthias; Wagh, Preshit R.; Mishra, Neha; Xue, Yonggan; Allawadhi, Prince; Beyer, Georg; Kuehn, Jens-Peter; Marshall, Thomas; Appel, Bettina; Laemmerhirt, Felix; Belka, Claus; Mueller, Sabine; Weiss, Frank-Ulrich; Lauber, Kirsten; Lerch, Markus M. und Mayerle, Julia
(2021):
Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models.
In: Gastroenterology, Bd. 161, Nr. 3: S. 996-1010